Reversal of intense neuromuscular blockade following infusion of atracurium

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Reversal of intense neuromuscular blockade following infusion of atracurium. / Engbaek, J.; Ostergaard, D.; Skovgaard, L. T.; Viby-Mogensen, J.

In: Anesthesiology, Vol. 72, No. 5, 1990, p. 803-806.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Engbaek, J, Ostergaard, D, Skovgaard, LT & Viby-Mogensen, J 1990, 'Reversal of intense neuromuscular blockade following infusion of atracurium', Anesthesiology, vol. 72, no. 5, pp. 803-806. https://doi.org/10.1097/00000542-199005000-00005

APA

Engbaek, J., Ostergaard, D., Skovgaard, L. T., & Viby-Mogensen, J. (1990). Reversal of intense neuromuscular blockade following infusion of atracurium. Anesthesiology, 72(5), 803-806. https://doi.org/10.1097/00000542-199005000-00005

Vancouver

Engbaek J, Ostergaard D, Skovgaard LT, Viby-Mogensen J. Reversal of intense neuromuscular blockade following infusion of atracurium. Anesthesiology. 1990;72(5):803-806. https://doi.org/10.1097/00000542-199005000-00005

Author

Engbaek, J. ; Ostergaard, D. ; Skovgaard, L. T. ; Viby-Mogensen, J. / Reversal of intense neuromuscular blockade following infusion of atracurium. In: Anesthesiology. 1990 ; Vol. 72, No. 5. pp. 803-806.

Bibtex

@article{1c6f792ae38b438393986f274c134a12,
title = "Reversal of intense neuromuscular blockade following infusion of atracurium",
abstract = "In order to evaluate reversal time from very intense neuromuscular blockade caused by a continuous infusion of atracurium, the time course of neostigmine induced reversal from different levels of neuromuscular blockade was evaluated using the post-tetanic count (PTC) and the train-of-four (TOF) in 30 patients anesthetized with nitrous oxide, fentanyl, and thiopental. Reversal time (time from administration of neostigmine at different PTC levels to a TOF ratio of 0.7) was found to depend upon the degree of blockade at the time of reversal. Median reversal time from a PTC of 1-2, 3-4, 5-6, 7-8, 9-10, 11-12, and > 13 (but less than 10% twitch height) to a TOF ratio of 0.7 was 31, 23, 19, 18, 14, and 13 min, respectively. Spontaneous recovery from PTC level of 1-2, when atracurium infusion was stopped, to a PTC level at which antagonism was induced and reversal time were both correlated to the square root of the PTC. Total recovery time (spontaneous recovery plus reversal time) was not shortened by an early injection of neostigmine. It is concluded that neostigmine administration during intense neuromuscular blockade following atracurium infusion does not shorten total recovery time and offers no clinical advantages.",
keywords = "Antagonist, neuromuscular relaxant: neostigmine, Monitoring: stimulation; nerve; post-tetanic count; train-of-four, Neuromuscular relaxant: atracurium",
author = "J. Engbaek and D. Ostergaard and Skovgaard, {L. T.} and J. Viby-Mogensen",
year = "1990",
doi = "10.1097/00000542-199005000-00005",
language = "English",
volume = "72",
pages = "803--806",
journal = "Anesthesiology",
issn = "0003-3022",
publisher = "Lippincott Williams & Wilkins",
number = "5",

}

RIS

TY - JOUR

T1 - Reversal of intense neuromuscular blockade following infusion of atracurium

AU - Engbaek, J.

AU - Ostergaard, D.

AU - Skovgaard, L. T.

AU - Viby-Mogensen, J.

PY - 1990

Y1 - 1990

N2 - In order to evaluate reversal time from very intense neuromuscular blockade caused by a continuous infusion of atracurium, the time course of neostigmine induced reversal from different levels of neuromuscular blockade was evaluated using the post-tetanic count (PTC) and the train-of-four (TOF) in 30 patients anesthetized with nitrous oxide, fentanyl, and thiopental. Reversal time (time from administration of neostigmine at different PTC levels to a TOF ratio of 0.7) was found to depend upon the degree of blockade at the time of reversal. Median reversal time from a PTC of 1-2, 3-4, 5-6, 7-8, 9-10, 11-12, and > 13 (but less than 10% twitch height) to a TOF ratio of 0.7 was 31, 23, 19, 18, 14, and 13 min, respectively. Spontaneous recovery from PTC level of 1-2, when atracurium infusion was stopped, to a PTC level at which antagonism was induced and reversal time were both correlated to the square root of the PTC. Total recovery time (spontaneous recovery plus reversal time) was not shortened by an early injection of neostigmine. It is concluded that neostigmine administration during intense neuromuscular blockade following atracurium infusion does not shorten total recovery time and offers no clinical advantages.

AB - In order to evaluate reversal time from very intense neuromuscular blockade caused by a continuous infusion of atracurium, the time course of neostigmine induced reversal from different levels of neuromuscular blockade was evaluated using the post-tetanic count (PTC) and the train-of-four (TOF) in 30 patients anesthetized with nitrous oxide, fentanyl, and thiopental. Reversal time (time from administration of neostigmine at different PTC levels to a TOF ratio of 0.7) was found to depend upon the degree of blockade at the time of reversal. Median reversal time from a PTC of 1-2, 3-4, 5-6, 7-8, 9-10, 11-12, and > 13 (but less than 10% twitch height) to a TOF ratio of 0.7 was 31, 23, 19, 18, 14, and 13 min, respectively. Spontaneous recovery from PTC level of 1-2, when atracurium infusion was stopped, to a PTC level at which antagonism was induced and reversal time were both correlated to the square root of the PTC. Total recovery time (spontaneous recovery plus reversal time) was not shortened by an early injection of neostigmine. It is concluded that neostigmine administration during intense neuromuscular blockade following atracurium infusion does not shorten total recovery time and offers no clinical advantages.

KW - Antagonist, neuromuscular relaxant: neostigmine

KW - Monitoring: stimulation; nerve; post-tetanic count; train-of-four

KW - Neuromuscular relaxant: atracurium

UR - http://www.scopus.com/inward/record.url?scp=0025361015&partnerID=8YFLogxK

U2 - 10.1097/00000542-199005000-00005

DO - 10.1097/00000542-199005000-00005

M3 - Journal article

C2 - 2160206

AN - SCOPUS:0025361015

VL - 72

SP - 803

EP - 806

JO - Anesthesiology

JF - Anesthesiology

SN - 0003-3022

IS - 5

ER -

ID: 259165858